Literature DB >> 8488548

Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices Committee.

C K Kasper1, J M Lusher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8488548     DOI： 10.1046/j.1537-2995.1993.33593255605.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  5 in total

Review 1.  Modern treatment of haemophilia.

Authors:  E Berntorp; V Boulyjenkov; D Brettler; M Chandy; P Jones; C Lee; J Lusher; P Mannucci; I Peak; K Rickard
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

2.  Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates.

Authors:  James G Clifton; Feilei Huang; Spomenka Kovac; Xinli Yang; Douglas C Hixson; Djuro Josic
Journal:  Electrophoresis       Date:  2009-10       Impact factor: 3.535

Review 3.  Treatment strategies in children with hemophilia.

Authors:  Pia Petrini
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Transfusion protocol in trauma.

Authors:  Paramjit Kaur; Sabita Basu; Gagandeep Kaur; Ravneet Kaur
Journal:  J Emerg Trauma Shock       Date:  2011-01

5.  Serum viral markers in Iranian patients with congenital bleeding disorder.

Authors:  Mohsen Nassirtoosi; Manije Lak; Katayoun Karimi; Mohammadreza Managchi; Katayoun Samimi-Rad; Alireza Abdollahi; Reza Shahsiah
Journal:  Ann Saudi Med       Date:  2008 Nov-Dec       Impact factor: 1.526
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.